This paper is in the following e-collection/theme issue:

Non-Randomized Studies (funded, non-eHealth) (155) HIV/AIDS/STI Prevention and Care (971) Longitudinal and Cohort Studies in Public Health (367) Cross-Sectional Studies in Public Health (367)

Published on in Vol 10, No 4 (2021): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/24731, first published .
Subclinical and Clinical Outcomes in Patients Coinfected With HIV and Chronic Hepatitis B Virus From Clinical Outpatient Centers in France: Protocol for an Ambispective, Longitudinal Cohort Study

Subclinical and Clinical Outcomes in Patients Coinfected With HIV and Chronic Hepatitis B Virus From Clinical Outpatient Centers in France: Protocol for an Ambispective, Longitudinal Cohort Study

Subclinical and Clinical Outcomes in Patients Coinfected With HIV and Chronic Hepatitis B Virus From Clinical Outpatient Centers in France: Protocol for an Ambispective, Longitudinal Cohort Study

Authors of this article:

Anders Boyd1 Author Orcid Image ;   Lorenza N C Dezanet1 Author Orcid Image ;   Raisha Kassime1 Author Orcid Image ;   Patrick Miailhes2 Author Orcid Image ;   Caroline Lascoux-Combe3 Author Orcid Image ;   Julie Chas4 Author Orcid Image ;   Pierre-Marie Girard1, 5 Author Orcid Image ;   Joël Gozlan5, 6 Author Orcid Image ;   Fabien Zoulim7 Author Orcid Image ;   Constance Delaugerre8 Author Orcid Image ;   Hayette Rougier9 Author Orcid Image ;   Karine Lacombe1, 5 Author Orcid Image
Article Authors Cited by (5) Tweetations (2) Metrics

Journals

  1. Dezanet L, Miailhes P, Lascoux‐Combe C, Chas J, Maylin S, Gabassi A, Rougier H, Delaugerre C, Lacombe K, Boyd A. Profiles of liver fibrosis evolution during long‐term tenofovir treatment in HIV‐positive patients coinfected with hepatitis B. Liver International 2021;41(12):2874 View
  2. Dezanet L, Kassime R, Miailhes P, Lascoux-Combe C, Chas J, Maylin S, Gabassi A, Rougier H, Delaugerre C, Lacombe K, Boyd A. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus–Hepatitis B Virus–Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort. Clinical Infectious Diseases 2022;74(6):1012 View
  3. Dezanet L, Miailhes P, Lascoux-Combe C, Chas J, Maylin S, Gabassi A, Rougier H, Delaugerre C, Lacombe K, Boyd A. Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study. Journal of Antimicrobial Chemotherapy 2021;76(11):3009 View
  4. Wang C, Zhang S, Zhao J, Wang M, Lu Q, Liu B, Du J, Cui F. Changes and gaps of global and regional disease burden of hepatitis B infection in children younger than 5 years old between 2015 and 2019: A real‐world data review. Journal of Medical Virology 2023;95(11) View
  5. Mohareb A, Miailhes P, Bottero J, Lascoux-Combe C, Chas J, Maylin S, Gabassi A, Rougier H, Hyle E, Delaugerre C, Lacombe K, Boyd A. Virological and serological outcomes in people with HIV-HBV coinfection who had discontinued tenofovir-containing antiretroviral therapy: Results from a prospective cohort study. Journal of Virus Eradication 2024;10(4):100574 View